Lifelong Medical Care Rodeo Health Center | |
25 California St Rodeo CA 94572-1310 | |
(510) 981-4100 | |
Not Available |
Full Name | Lifelong Medical Care Rodeo Health Center |
---|---|
Speciality | Family Medicine |
Location | 25 California St, Rodeo, California |
Authorized Official Name and Position | Martin Lynch (CHIEF EXECUTIVE OFFICER) |
Authorized Official Contact | 5109814123 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Lifelong Medical Care Rodeo Health Center Po Box 11247 Berkeley CA 94712-2247 Ph: (510) 981-4122 | Lifelong Medical Care Rodeo Health Center 25 California St Rodeo CA 94572-1310 Ph: (510) 981-4100 |
NPI Number | 1003289463 |
---|---|
Provider Enumeration Date | 11/06/2015 |
Last Update Date | 01/16/2024 |
Identifier | Type | State | Issuer |
---|---|---|---|
1003289463 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
An intervention based around family psychoeducation reduces symptoms and improves functioning in patients at clinical high risk of psychosis or experiencing early first-episode psychosis, say researchers.
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a study by researchers at the Stanford University School of Medicine.
Dr. Reddy's Laboratories announced today that it launched amlodipine benazepril capsules (2.5mg/10mg, 5mg/10mg, 5mg/20mg, 10mg/20mg), a bioequivalent generic version of Lotrel Capsules, in the US market on April 23, 2010.
› Verified 5 days ago